Succinylcholine infusion associated with hyperthermia in ponies anesthetized with halothane.

This study investigated the effects of succinylcholine on halothane-anesthetized ponies for surgical relaxation purposes but reported severe reactions that were similar to malignant hyperthermia symptoms in four of the six ponies examined.

Objective and Method

• The main objective of the research was to identify the dosage requirements for using succinylcholine, a muscle relaxant, with halothane anesthesia in ponies for surgical relaxation for up to three hours duration.
• The researchers administered succinylcholine via infusion to ponies under halothane anesthesia and monitored physiological factors continuously.

Findings

• The researchers found that providing the intended dosage of succinylcholine was not possible due to severe reactions observed in four out of the six ponies studied.
• The reactions included prolonged muscle fasciculations after the initial succinylcholine dose, muscle rigidity, hyperthermia, high levels of carbon dioxide in the blood (hypercapnia), rapid heart rate (tachycardia), increased pulse pressure, and metabolic acidosis.
• These reactions resemble those linked with malignant hyperthermia, a severe and potentially life-threatening reaction to certain drugs used during general anesthesia, recognized in humans and swine.

Other Observations

• Two ponies demonstrated symptoms of the phase II or desensitization block of succinylcholine, a stage where the body seems resistant to the muscle-relaxing effects of the drug.
• All ponies were able to recover from anesthesia with no signs of muscle injury.

Conclusion

• The study concludes that the use of succinylcholine in halothane-anesthetized ponies may result in serious complications, similar to those in malignant hyperthermia.
• Despite the unfavorable reactions, all tested ponies recovered from anesthesia with no signs of muscle injury.